[Use of sydnopharm and silabolin in patients with chronic cor pulmonale].
Bondarenko
I P
IP
D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001991:Bronchitis / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004963:Estrenes / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000009:adverse effects / Q000627:therapeutic use*; D011660:Pulmonary Heart Disease / Q000188:drug therapy* / Q000503:physiopathology; D012825:Silicon / Q000627:therapeutic use*; D014297:Trimethylsilyl Compounds / Q000009:adverse effects / Q000627:therapeutic use*
D045930:Anabolic Agents; D004963:Estrenes; D014297:Trimethylsilyl Compounds; C050044:silabolin; D008981:Molsidomine; D012825:Silicon
Primenenie sidnofarma i silabolina u bol'nykh khronicheskim legochnym serdtsem.